Peter J. O’Dwyer, MD
Dr. O’Dwyer is the Group Co-Chair of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) since May 2017. He co-leads the organization’s governance and is a member of several scientific committees. He co-chairs the landmark precision medicine cancer trial known as NCI-MATCH. A medical oncologist with expertise in gastrointestinal and pancreatic cancers, Dr. O’Dwyer is a physician at Penn Medicine in Philadelphia and a professor of medicine at the University of Pennsylvania since 1999. He is the CEO and Chair of the PrECOG, LLC Board of Managers, President of the ECOG-ACRIN Medical Research Foundation, and President of the ECOG Research and Education Foundation.
Dr. O’Dwyer received his medical degree at the University of Dublin, Trinity College, and completed his residency at the Hammersmith Hospital in London. After a fellowship at the Baltimore Cancer Research Center, he became a senior investigator in the Division of Cancer Treatment at the National Cancer Institute. Dr. O'Dwyer previously led the Developmental Therapeutics Programs at Fox Chase Cancer Center and the University of Pennsylvania. He has more than 350 scientific papers in medical literature and participates in numerous national and international organizations.